| 1 |
30589625 | Implications of Removing Rosiglitazone's Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes. | 2019 Jan |
1 |
| 2 |
27067162 | Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System. | 2016 May |
1 |
| 3 |
20455069 | Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. | 2012 Dec |
2 |